IU researchers using high-performance computing to improve cancer treatment
Indiana University researchers are revolutionizing cancer treatment by developing "digital twins" of the human immune system, using the Big Red 200 supercomputer. This approach, led by Paul Macklin, aims to create tailored cancer therapies by simulating individual cancer and immune cell interactions. Collaborating with Johns Hopkins University and Oregon Health & Science University, the team focuses on breast and pancreatic cancers, integrating real-world patient data to predict the most effective treatment strategies.